Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1612 1615 1626 1743 3785
This examiner grants 72% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18498117 | DEODORANT COMPOSITIONS | Non-Final OA | The Procter & Gamble Company |
| 17961089 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | Non-Final OA | The Procter & Gamble Company |
| 18939379 | SALBUTAMOL DELIVERY COMPOSITIONS, DEVICES AND METHODS | Non-Final OA | HONEYWELL INTERNATIONAL INC. |
| 18036209 | DELAYED RELEASE SOFTGEL CAPSULES | Final Rejection | R.P. Scherer Technologies, LLC |
| 18437509 | COMPOSITIONS AND DEVICES INCORPORATING WATER-INSOLUBLE THERAPEUTIC AGENTS AND METHODS OF THE USE THEREOF | Non-Final OA | Cook Medical Technologies LLC |
| 19242195 | COMPOSITIONS, DEVICES, AND METHODS FOR INTRANASAL DELIVERY OF DRY POWDER EPINEPHRINE | Non-Final OA | Belhaven BioPharma Inc. |
| 18514634 | DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS | Non-Final OA | Belhaven BioPharma Inc. |
| 18898086 | COMPOSITIONS AND METHODS FOR TREATING HAIR | Non-Final OA | L'Oreal |
| 18547596 | ANTIMICROBIAL WET WIPES | Non-Final OA | Kimberly-Clark Worldwide, Inc. |
| 18951119 | CLEANSING AGENT | Non-Final OA | Shiseido Company, Ltd. |
| 18869925 | MOLECULARLY CLEAVABLE BIOINK FORMULATION | Non-Final OA | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. |
| 18246582 | GASTRO RETENTIVE DOSAGE FORMS COMPRISING DEUTETRABENAZINE | Final Rejection | AUSPEX PHARMACEUTICALS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy